IL88433A0 - Diarylstyrylquinoline diacids and pharmaceutical compositions containing them - Google Patents
Diarylstyrylquinoline diacids and pharmaceutical compositions containing themInfo
- Publication number
- IL88433A0 IL88433A0 IL88433A IL8843388A IL88433A0 IL 88433 A0 IL88433 A0 IL 88433A0 IL 88433 A IL88433 A IL 88433A IL 8843388 A IL8843388 A IL 8843388A IL 88433 A0 IL88433 A0 IL 88433A0
- Authority
- IL
- Israel
- Prior art keywords
- diarylstyrylquinoline
- diacids
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12505087A | 1987-11-25 | 1987-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL88433A0 true IL88433A0 (en) | 1989-06-30 |
Family
ID=22417988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL88433A IL88433A0 (en) | 1987-11-25 | 1988-11-21 | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0318093A3 (de) |
| JP (1) | JPH0686433B2 (de) |
| KR (1) | KR890008104A (de) |
| AU (1) | AU2589688A (de) |
| CA (1) | CA1339802C (de) |
| DK (1) | DK655288A (de) |
| IL (1) | IL88433A0 (de) |
| NZ (1) | NZ227036A (de) |
| PT (1) | PT89075B (de) |
| ZA (1) | ZA888766B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204358A (en) * | 1987-11-25 | 1993-04-20 | Merck Frosst Canada, Inc. | Hetaryl styryl quinolines as leukotriene inhibitors |
| US4968702A (en) * | 1989-01-17 | 1990-11-06 | American Cyanamid Company | Substituted quinolinecarboxylic acids |
| NZ233752A (en) * | 1989-05-24 | 1993-05-26 | Merck Frosst Canada Inc | Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof |
| DE3927930A1 (de) * | 1989-08-24 | 1991-02-28 | Bayer Ag | Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate |
| US5021576A (en) * | 1989-10-27 | 1991-06-04 | American Home Products Corporation | 2-Anilino phenylacetic acid derivatives |
| CA2053209C (en) * | 1990-10-12 | 1998-12-08 | Michel L. Belley | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| DE69113735T2 (de) * | 1990-10-12 | 1996-06-13 | Merck Frosst Canada Inc | Hydroxyalkylchinolin Äther Säure als Leukotrien-Antagoniste. |
| EP0480716A1 (de) * | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Gesättigte Hydroxyalkylchinolinsäuren zur Verwendung als Leukotrien-Antagonisten |
| US5856322A (en) * | 1990-10-12 | 1999-01-05 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
| US5149703A (en) * | 1991-09-06 | 1992-09-22 | Merck Frosst Canada, Inc. | Quinoline-substituted chromans and related compounds as leukotriene antagonists |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5506227A (en) * | 1992-04-13 | 1996-04-09 | Merck Frosst Canada, Inc. | Pyridine-substituted benzyl alcohols as leukotriene antagonists |
| EP0780127A1 (de) | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | Nasenspray enthaltend einen Steroid und einen Antihistamin |
| AU3868497A (en) * | 1996-08-26 | 1998-03-19 | Yamanouchi Pharmaceutical Co., Ltd. | Benzenesulfone compounds and salts thereof |
| EP0960096B1 (de) * | 1997-01-22 | 2005-04-06 | Aventis Pharmaceuticals Inc. | Substituierte beta-thiocarbonsäuren |
| FR2761687B1 (fr) * | 1997-04-08 | 2000-09-15 | Centre Nat Rech Scient | Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques |
| JP4725634B2 (ja) * | 2008-11-13 | 2011-07-13 | トヨタ自動車株式会社 | 無段変速機 |
| EP2736885B1 (de) | 2011-07-26 | 2020-03-25 | Sun Pharma Advanced Research Company Ltd | Cysteinyl-leukotrien-antagonisten |
| EP2964611B1 (de) | 2013-03-08 | 2022-10-19 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Wirksame und selektive inhibitoren von monoamintransportern, verfahren zur herstellung und verwendung davon |
| US11365195B2 (en) | 2017-11-13 | 2022-06-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Atypical inhibitors of monoamine transporters; method of making; and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK282986A (da) * | 1985-06-18 | 1987-02-24 | Merck Frosst Canada Inc | Substitueret quinolin og farmaceutisk praeparat indeholdende en saadan forbindelse |
| IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
| JPS63503139A (ja) * | 1986-03-13 | 1988-11-17 | ローラー インターナショナル（オーバーシーズ）インコーポレーテッド | 高血圧疾患治療剤としてのキノリニルエ−テル又はチオエ−テルテトラゾ−ル類 |
-
1988
- 1988-11-21 IL IL88433A patent/IL88433A0/xx unknown
- 1988-11-21 EP EP19880202606 patent/EP0318093A3/de not_active Ceased
- 1988-11-22 NZ NZ227036A patent/NZ227036A/xx unknown
- 1988-11-22 CA CA000583726A patent/CA1339802C/en not_active Expired - Fee Related
- 1988-11-23 ZA ZA888766A patent/ZA888766B/xx unknown
- 1988-11-24 AU AU25896/88A patent/AU2589688A/en not_active Abandoned
- 1988-11-24 DK DK655288A patent/DK655288A/da unknown
- 1988-11-24 KR KR1019880015470A patent/KR890008104A/ko not_active Withdrawn
- 1988-11-24 PT PT89075A patent/PT89075B/pt not_active IP Right Cessation
- 1988-11-25 JP JP63296383A patent/JPH0686433B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0318093A3 (de) | 1990-12-05 |
| KR890008104A (ko) | 1989-07-08 |
| PT89075A (pt) | 1988-12-01 |
| EP0318093A2 (de) | 1989-05-31 |
| DK655288A (da) | 1989-08-04 |
| PT89075B (pt) | 1993-04-30 |
| AU2589688A (en) | 1989-06-01 |
| ZA888766B (en) | 1989-08-30 |
| JPH0686433B2 (ja) | 1994-11-02 |
| NZ227036A (en) | 1991-10-25 |
| DK655288D0 (da) | 1988-11-24 |
| CA1339802C (en) | 1998-04-07 |
| JPH02138259A (ja) | 1990-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL82221A0 (en) | Phenyl-piperazines and pharmaceutical compositions containing them | |
| IL95351A0 (en) | 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them | |
| IL87079A0 (en) | Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them | |
| NZ222980A (en) | 3-aryloxy-3-substituted propanamines and pharmaceutical compositions | |
| NZ223096A (en) | Peptidylaminodiols and pharmaceutical compositions | |
| IL74365A (en) | 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it | |
| IL90067A0 (en) | 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them | |
| IL85896A (en) | Substituted di-tert.- butylphenols and pharmaceutical compositions containing them | |
| NZ223875A (en) | 9-aminotetrahydroacridines and related homologues and pharmaceutical compositions | |
| IL86086A0 (en) | Bifunctional proteins and pharmaceutical compositions containing them | |
| IL88433A0 (en) | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them | |
| GR871659B (en) | Substituted a-aminoacids their preparation and pharmaceutical compositions containing them | |
| NZ226002A (en) | Peptidylheterocyclic compounds and pharmaceutical compositions | |
| GB2207922B (en) | Tripeptides and pharmaceutical compositions containing them | |
| NZ226450A (en) | Crystalline-1-carbacephalosporin and pharmaceutical compositions | |
| IL79376A (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them | |
| IL87800A0 (en) | Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them | |
| IL87644A0 (en) | Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them | |
| IL85969A0 (en) | Ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| IL79003A0 (en) | Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them | |
| IL86926A0 (en) | 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them | |
| NZ219748A (en) | Indenopyrimidines and pharmaceutical compositions | |
| IL92650A0 (en) | Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them | |
| IL86155A0 (en) | Benzenesulfonamides and pharmaceutical compositions containing them | |
| IL78918A (en) | Spiroheterocyclically-condensed hexahydroaryl-quinolizines and pharmaceutical compositions containing them |